SCHEMBL10176560

SCHEMBL10176560

COc1ccc(C(O)c2cccc(-c3cc4cc(F)ccc4n3S(=O)(=O)c3ccccc3)c2)cc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 11/20 0.46
PDE4A P27815 3/20 0.46
PDE4B Q07343 3/20 0.46
PDE4C Q08493 3/20 0.46
PDE4D Q08499 3/20 0.46
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
HTT P42858 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CA12 O43570 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
TUBB4A P04350 1/20 0.37
TUBB P07437 1/20 0.37
TUBA3C P0DPH7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL429321 0.92 ACLY (0.46) ACLYPDE4APDE4BPDE4CPDE4D
SCHEMBL428256 0.90 PDE4A (0.52) ACLYPDE4APDE4BPDE4CPDE4D
SCHEMBL430039 0.81 TUBB4A (0.49) ACLYPDE4APDE4BPDE4CPDE4D
SCHEMBL10176556 0.81 PDE4A (0.53) ACLYPDE4APDE4BPDE4CPDE4D
SCHEMBL423304 0.79 CA12 (0.48) ACLYPDE4APDE4BPDE4CPDE4D
SCHEMBL422049 0.78 CA12 (0.49) ACLYPDE4APDE4BPDE4CPDE4D
SCHEMBL424367 0.78 CA12 (0.48) ACLYPDE4APDE4BPDE4CPDE4D
SCHEMBL428054 0.77 CA12 (0.57) ACLYALDH1A1MAPTLMNACA12
SCHEMBL3558271 0.77 ACLY (0.67) ACLYALDH1A1MAPTCA12CA2
SCHEMBL10176544 0.77 ACLY (0.48) ACLYTUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-01-26 US disclosed
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR TUBB, TUBB3, TUBB1 ACLY 3445/4885PDE4A 2473/4885PDE4B 2107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.